Klaus Charisse Alnylam Pharmaceuticals, Inc. Biography Publications Institution JoVE Articles Klaus Charisse has not added a biography. If you are Klaus Charisse and would like to personalize this page please email our Author Liaison for assistance. Publications Molecularly Self-assembled Nucleic Acid Nanoparticles for Targeted in Vivo SiRNA Delivery Nature Nanotechnology. 2012 | Pubmed ID: 22659608 RNA (New York, N.Y.). Mar, 2012 | Pubmed ID: 22294662 Experimental Neurology. Jan, 2012 | Pubmed ID: 22119622 Angewandte Chemie (International Ed. in English). Mar, 2011 | Pubmed ID: 21351337 The Journal of Organic Chemistry. Mar, 2011 | Pubmed ID: 21299239 Nucleic Acids Research. Nov, 2010 | Pubmed ID: 20610434 Nucleic Acids Research. Aug, 2010 | Pubmed ID: 20403811 Analytical Biochemistry. Jun, 2010 | Pubmed ID: 20156415 Oligonucleotides. Mar, 2009 | Pubmed ID: 19093781 Molecular Neurodegeneration. 2008 | Pubmed ID: 18976489 Therapeutic RNAi Targeting PCSK9 Acutely Lowers Plasma Cholesterol in Rodents and LDL Cholesterol in Nonhuman Primates Proceedings of the National Academy of Sciences of the United States of America. Aug, 2008 | Pubmed ID: 18695239 Nature. Nov, 2004 | Pubmed ID: 15538359 An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment Moo Rim Kang*1, Glen Yang*1, Klaus Charisse2, Hila Epstein-Barash2, Muthiah Manoharan2, Long-Cheng Li1 1Department of Urology and Helen Diller Comprehensive Cancer Center, University of California, San Francisco, 2Alnylam Pharmaceuticals, Inc. JoVE 4207 Médecine
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment Moo Rim Kang*1, Glen Yang*1, Klaus Charisse2, Hila Epstein-Barash2, Muthiah Manoharan2, Long-Cheng Li1 1Department of Urology and Helen Diller Comprehensive Cancer Center, University of California, San Francisco, 2Alnylam Pharmaceuticals, Inc. JoVE 4207 Médecine